These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28545047)

  • 41. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States.
    Patel MS; Gebremariam A; Davis MM
    Infect Control Hosp Epidemiol; 2008 Dec; 29(12):1157-63. PubMed ID: 18999945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of varicella vaccination on herpes zoster incidence.
    Wagenpfeil S; Neiss A; Wutzler P
    Clin Microbiol Infect; 2004 Nov; 10(11):954-60. PubMed ID: 15521996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of shingles by varicella zoster virus vaccination.
    Holodniy M
    Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.
    Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M
    J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data.
    Guzzetta G; Poletti P; Del Fava E; Ajelli M; Scalia Tomba GP; Merler S; Manfredi P
    Am J Epidemiol; 2013 May; 177(10):1134-42. PubMed ID: 23548754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What does epidemiology tell us about risk factors for herpes zoster?
    Thomas SL; Hall AJ
    Lancet Infect Dis; 2004 Jan; 4(1):26-33. PubMed ID: 14720565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?
    Gershon AA
    J Infect; 2017 Jun; 74 Suppl 1(Suppl 1):S27-S33. PubMed ID: 28646959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
    Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
    Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Vaccination against herpes-zoster: a new strategy for post-herpetic neuralgia].
    Gil de Miguel A
    An R Acad Nac Med (Madr); 2009; 126(1):57-66; discussion 67-72. PubMed ID: 20432659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Varicella zoster virus transmission dynamics in Vojvodina, Serbia.
    Medić S; Katsilieris M; Lozanov-Crvenković Z; Siettos CI; Petrović V; Milošević V; Brkić S; Andrews N; Ubavić M; Anastassopoulou C
    PLoS One; 2018; 13(3):e0193838. PubMed ID: 29505590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccine profile of herpes zoster (HZ/su) subunit vaccine.
    Cunningham AL; Heineman T
    Expert Rev Vaccines; 2017 Jul; 16(7):1-10. PubMed ID: 28486850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [How I prevent...herpes zoster by vaccination].
    Nikkels AF; Piérard GE
    Rev Med Liege; 2007 Jan; 62(1):44-7. PubMed ID: 17343129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
    Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
    Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology of Varicella-Zoster Virus in England and Wales.
    Brisson M; Edmunds WJ
    J Med Virol; 2003; 70 Suppl 1():S9-14. PubMed ID: 12627480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study.
    Wen SY; Liu WL
    Pediatrics; 2015 Mar; 135(3):e565-71. PubMed ID: 25713285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.